Clinical trial
The Study of Atypical Antipsychotics-induced Metabolic Disturbances
NCT00937755 is registered in ClinicalTrials.gov with Taipei Medical University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Study of Atypical Antipsychotics-induced Metabolic Disturbances
- Lead sponsor
- Taipei Medical University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2006
- Completion date
- May 31, 2009
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antipsychotics, schizophrenia